ArticleEvidence-based medicine2011

Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions.

Monique J Roobol et al.PubMed ↗Publisher ↗

No numbers read from the abstract.